Who invested in Tolremo?
One investor is on record as having backed Tolremo — Developing drugs to stop cancer resistance, in Biotech, Switzerland. Each row below says whether the round came from the investor's own portfolio page or from the press.
tolremo.comTolremo investors
The funds that backed Tolremo are in the directory.
If they wrote this cheque, they may write yours. Pitch2Fund scores your startup against every one of them, gives you the partner to write to, and drafts the email. Free.